Skip to Content

Risk Management for Pharmaceutical Operations

Unit code: HES6429

Credit points12.5 Credit Points
Duration

1 Semester or Teaching Period

Contact hours30 hours
CampusExternal Venue, Hawthorn
Prerequisites

Nil, however a basic understanding of, GMP and practical work experience within the industry is assumed. Completion, or co-completion, of HES6401, HES6402and HES6403 is therefore desirable.

Corequisites

Aims and objectives

To facilitate the development of knowledge, and expertise in risk management principles and practical risk evaluation techniques, in order to identify and manage risks in the development, manufacture and marketing of pharmaceuticals.

At the end of this unit students will be able to:

  • Articulate and evaluate the principles influencing the practice of risk management in pharmaceutical operations; make judgments based on risk management principles.
  • Utilise risk evaluation techniques to analysis pharmaceutical products, operations and systems; and propose control strategies and plans to mitigate unacceptable risk and loss to the organisation.
  • Demonstrate skills in writing reports. Research, assess and evaluate information. Evaluate data and identify facts.

Teaching methods

Lectures/Tutorials, Laboratory and/or experiential off-campus learning, Case studies based on actual events that have occurred in the pharmaceutical and related industries will be used, Web Based Unit Presence (Blackboard).

 

Assessment

Mid Term Exam: multiple choice, short answer: 30 minutes: 10%
Final Term Exam: essay type questions: 90 minutes:  30%
Assignments:  one project of approximately 1500 words or equivalent:  60%

Generic skills outcomes

Students will be provided with feedback during the assessment for this unit of study on their progress in attaining the following generic skills:

  • Teamwork skills,
  • Analysis skills,
  • Problem solving skills,
  • Communications skills,
  • Ability to tackle unfamiliar problems, and the
  • Ability to work independently

Content

Principles of risk management (analysis, control and management)
Regulatory guidance for applying risk management in pharmaceuticals – FDA, EU/PICs/TGA, ICH
Risk analysis and risk control applications in design control
Quality by Design - Risk analysis in design and development of products
Application of risk analysis and risk to quality management systems and CAPA systems
Application of risk assessment for managing product complaints
Application of risk analysis in compliance and auditing of pharmaceutical operations
Hazard Analysis and Critical Control Point (HACCP) in production and process control
Application of risk principles in commissioning, qualification and process validation
Development a of Risk Management Master Plan

Reading materials

FDA - Pharmaceutical CGMPs for the 21st Century Initiative. (August 2002,)
EU/PICs/TGA cGMP – Annex 15 Qualification and Validation
FDA Guidance for Industry Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations
ICH Q8 – Pharmaceutical Development
ICH Q9 – Quality Risk Management
ICH Q10 – Quality Management Systems
ANSI/AAMI/ISO Standard13485:2003 Medical devices – Quality management systems- Requirements for regulatory purposes
ISO 14971:2000 - Application of Risk Management to Medical Devices
ASTM E55.03 (Draft) (WK9864) Standard Guide for a Science and Risk Based Approach to Qualification of Biopharmaceutical and Pharmaceutical Manufacturing Systems)

Text books

Printed notes will be supplied